References
- Barbato E, Piscione F, Bartunek J, Galasso G, Cirillo P, De Luca G, Iaccarino G, De Bruyne B, Chiariello M, Wijns W. (2005). Role of β2 adrenergic receptors in human atherosclerotic coronary arteries. Circulation 111: 288-294.
- Bauerova K, Ponist S, Ondrejickova O, Komendova D, Mihalova D. (2006). Association between tissue gamma-glutamyltransferase and clinical markers of adjuvant arthritis in Lewis rats. Neuro Endocrinol Lett 27: 172-175.
- Broskova Z, Knezl V. (2011). Protective effect of novel pyridoindole derivatives on ischemia/reperfusion injury of the isolated rat heart. PharmacolRep 63: 967-974.
- Dubovicky M, Ujhazy E, Kovacovsky P, Rychlik I, Jansak J. (1999). Evaluation of long-term administration of the antioxidant stobadine on exploratory behaviour in rats of both genders. J Appl Toxicol. 19: 431-436.
- Esenabhalu VE, Cerimagic M, Malli R, Osibow K, Levak-Frank S, Frieden M, Sattler W, Kostner GM, Zechner R, Graier WF. (2002). Tissue-specific expression of human lipoprotein lipase in the vascular system affects vascular reactivity in transgenic mice. Br J Pharmacol 135: 143-154.
- Franko J, Pomfy M, Novakova B, Benes L. (1999). Stobadine protects against ischemia-reperfusion induced morphological alterations of cerebral microcirculation in dogs. Life Sci 65: 1963-1967.
- Freitas MG, Schott C, Corriu S, Sassard J, Stoclet JC, Andriantsitohaina R. (2003). Heterogeneity of endothelium-dependent vasorelaxation in conductance and resistance arteries from Lyon normotensive and hypertensive rats. J Hypertens 21: 1505-1512.
- Gajdosikova A, Ujhazy E, Gajdosik A, Chalupa I, Blasko M, Tomaskova A, Liska J, Dubovicky M, Bauer V. (1995). Chronic toxicity and micronucleus assay of the new cardioprotective agent stobadine in rats. Arzneimittelforschung45:531-536.
- Juranek I, Horakova L, Rackova L, Stefek M. (2010). Antioxidants in treating pathologies involving oxidative damage: an update on medicinal chemistry and biological activity of stobadine and related pyridoindoles. Cur MedChem 17: 552-570.
- Kvaltinova Z, Lukovic L and Machova J. (1986). Alpha1-adrenoceptor blocking action of DH 1011. J Pharmac (Paris) 17: 187.
- Lukovic L and Machova J. (1988). Antihistaminic activity of stobadine in the peripheral and central nervous system. Agents Actions 23: 257-259.
- Stasko A, Ondrias K, Misik V, Szocsova H, Gergel D. (1990). Stobadine - a novel scavenger of free radicals. Chem Pap 44: 493-500.
- Stolc S, Snirc V, Gajdosikova A, Gajdosik A, Gasparova Z, Ondrejickova O, Sotnikova R, Viola A, Rapta P, Jariabka P, Synekova I, Vajdova M, Zacharova S, Nemcek V, Krchnarova V. (2008). New pyridoindoles with antioxidant and neuroprotective actions. In Trends in Pharmacological Research; Bauer, V. Ed.; Institute of Experimental Pharmacology: Bratislava, 2008, 118-36.
- Stolc S, Snirc V, Majekova M, Gasparova Z, Gajdosikova A, Stvrtina S. (2006). Development of the new group of indole-derived neuroprotective drugs affecting oxidative stress. Cell Mol Neurobiol 26: 1495-1504.
- Yano M, Hasegawa G, Ishii M, Yamasaki M, Fukui M, Nakamura N, Yoshikawa T. (2004). Short-term exposure of high glucose concentration induces generation of reactive oxygen species in endothelial cells: implication for the oxidative stress associated with postprandial hyperglycemia. Redox Rep 9: 111-116.
- Zurova-Nedelcevova J, Navarova J, Drabikova K, Jancinova V, Petrikova M, Bernatova I, Kristova V, Snirc V, Nosalova V, Sotnikova R.(2006). Participation of reactive oxygen species in diabetes-induced endothelial dysfunction. Neuro Endocrinol Lett 27: 168-171.